CAR T-cell Therapy JCAR017 Shows Sustained Anticancer Response in Aggressive B-Cell Lymphoma, Trial Update … – Lymphoma News Today
Lymphoma News Today |
CAR T-cell Therapy JCAR017 Shows Sustained Anticancer Response in Aggressive B-Cell Lymphoma, Trial Update …
Lymphoma News Today Treatment with the CAR T-cell therapy JCAR017 (lisocabtagene maraleucel, or liso-cel) provided a durable reduction or eradication of cancer in patients with aggressive forms of B-cell non-Hodgkin’s lymphoma (NHL), long-term data from a Phase 1 trial … |
Medical Xpress |
Baby born in world’s first in utero stem cell transplant trial
Medical Xpress UC San Francisco researchers have safely transplanted a woman’s stem cells into her growing fetus, leading to the live birth of an infant with a normally fatal fetal condition. The infant, who had been critically ill during the second-trimester of … |